XGN (STOCKS)
Exagen Inc. Common Stock
$6.590000
+0.000000 (+0.00%)
Prev close: $6.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- John Aballi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $224.12M
- Employees
- 209
- P/E (TTM)
- -8.17
- P/B (TTM)
- 13.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $71.12M |
| Benefits Costs and Expenses | $54.91M |
| Cost Of Revenue | $29.42M |
| Costs And Expenses | $54.91M |
| Gross Profit | $41.70M |
| Operating Expenses | $54.91M |
| Selling, General, and Administrative Expenses | $48.45M |
| Research and Development | $6.47M |
| Operating Income/Loss | -$13.21M |
| Income/Loss From Continuing Operations After Tax | -$18.92M |
| Income/Loss From Continuing Operations Before Tax | $8.55M |
| Income Tax Expense/Benefit | $50.00K |
| Net Income/Loss | -$18.92M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.92M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.81 |
| Diluted Earnings Per Share | -$0.81 |
| Basic Average Shares | 71,639,850 |
| Diluted Average Shares | 71,639,850 |
| Assets | $51.94M |
| Current Assets | $42.86M |
| Noncurrent Assets | $9.08M |
| Liabilities | $39.72M |
| Current Liabilities | $13.46M |
| Accounts Payable | $4.44M |
| Other Current Liabilities | $9.02M |
| Noncurrent Liabilities | $26.26M |
| Long-term Debt | $22.84M |
| Other Non-current Liabilities | $3.42M |
| Equity | $12.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $12.22M |
| Liabilities And Equity | $51.94M |
| Net Cash Flow From Operating Activities | -$6.50M |
| Net Cash Flow From Operating Activities, Continuing | -$6.50M |
| Net Cash Flow From Investing Activities | -$1.08M |
| Net Cash Flow From Investing Activities, Continuing | -$1.08M |
| Net Cash Flow From Financing Activities | $2.13M |
| Net Cash Flow From Financing Activities, Continuing | $2.13M |
| Net Cash Flow | -$5.45M |
| Net Cash Flow, Continuing | -$5.45M |
| Comprehensive Income/Loss | -$18.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.92M |
| Other Comprehensive Income/Loss | $0.00 |